Table 2.

Summary relative risk (SRR) for cancers other than NMSC among those with prior NMSC, compared with those with no prior NMSC

NMSCSRR (95% CI)*I2
Individual-level cohort studies (n = 3)1.49 (1.12-1.98)92%
Registry-based studies (n = 12)1.12 (1.07-1.17)93%
    Males (n = 12)1.14 (1.09-1.20)89%
    Females (n = 12)1.10 (1.04-1.15)79%
    BCC (n = 7)1.09 (1.01-1.17)95%
        Males (n = 7)1.09 (1.00-1.18)93%
        Females (n = 7)1.09 (1.02-1.16)82%
    SCC (n = 7)1.17 (1.12-1.23)78%
        Males (n = 7)1.20 (1.15-1.26)61%
        Females (n = 7)1.09 (1.00-1.19)75%
  • *95% confidence interval.

  • CI excludes 1.00.